8:00-8:30 |
Registration and Coffee |
8:30-8:45 |
Overview of the Bioelectronic Medicine Industry James Cavuoto, Editor and Publisher, Neurotech Reports
Neurotech Business Report Editor James Cavuoto presents an overview of the bioelectronic medicine industry, including key players, technological roots, and market projections. |
8:45-9:15 |
Keynote Address
Sue Siegel, Chief Innovation Officer, CEO, GE Ventures
This keynote session features observations from a major investor and innovator in the medical device industry. |
9:15-10:00 |
Investment in Bioelectronic Medicine
Imran Eba, Partner, Action Potential Venture Capital, Moderator
Evan Norton, Divisional Vice President, Abbott Ventures
Jeff Erb, Senior Director, Business Development, Medtronic
Eric Van Gieson, Ph.D., Program Manager, DARPA
In this session, investment professionals active in the life sciences industry will offer their views on the investment climate for bioelectronic medicine. |
10:00-10:30 |
Refreshment Break |
10:30-11:15 |
Entrepreneur Panel I
James Cavuoto, Editor and Publisher, Neurotech Reports, Moderator
Thomas Oxley, M.D., Ph.D., CEO and Founder, Synchron Inc.
Gaurev Sharma, Ph.D., Technical Leader in Neuromodulation, Battelle
Jacob Zabara, Ph.D., President, Jacob Zabara Family Foundation
Presentations from executives of emerging bioelectronic medicine firms. |
11:15-12:00 |
New Devices Up Our Sleeve: Neuromodulation Gets Personal
Jennifer French, Senior Editor, Neurotech Reports, Moderator
Marom Bikson, Ph.D., Director, Neural Engineering Laboratory, CCNY
Shai Gozani, M.D., Ph.D., President and CEO, Neurometrix Inc.
Bioelectronic medicine now incorporates new wearable diagnostic, therapeutic, and software devices and vendors are exploring new distribution channels and revenue models. In this session, we'll discuss trends in digital health, direct-to-consumer marketing, and pay-per-dose pricing. |
12:00-1:30 |
Luncheon
|
1:30-2:15 |
Regulatory and Reimbursement Issues
Jeremy Koff, Senior Contributing Editor, Neurotech Reports, Moderator
Victor Pikov, Ph.D., CEO, Medipace, Inc.,
Startup and established bioelectronic medicine firms face a variety of regulatory and reimbursement issues on the way to commercialization. In this closing session, we'll explore key considerations in designing clinical trials, obtaining FDA approval, and getting reimbursement from payors. |
2:15-3:00 |
Entrepreneur Panel II
James Cavuoto, Editor, Neurotech Reports, Moderator
Jennifer Ernst, CEO, Tivic Health
Don Deyo, CEO, FemPulse LLC
Samuel Hamner, Ph.D., Director of Technology and Product Marketing, Cala Health
Presentations from executives of emerging bioelectronic medicine firms. |
3:00-3:30 |
Refreshment Break |
3:30-4:15 |
Entrepreneur Panel III
James Cavuoto, Editor, Neurotech Reports, Moderator
Daniel Powell, CEO, Spark Biomedical
Douglas Adams, CEO, Qura Inc.
Bill Edelman, CEO, Highland Instruments
Presentations from executives of emerging bioelectronic medicine firms. |
4:15-5:00 |
Future Outlook for Bioelectronic Medicine
James Cavuoto, Editor and Publisher, Neurotech Reports, Moderator
Kip Ludwig, Ph.D., Director, Bioelectronic Medicines Laboratory, University of Wisconsin
Elliot Krames, M.D., Former President, International Neuromodulation Society
Jeff Kramer, Ph.D., Vice-President, Research and Technology, Medtronic plc
In this closing session, we'll look at new applications for bioelectronic medicine, including potential therapies for treating immunological, dematalogical, and hematalogical disorders. |
5:00-7:00 |
Cocktail Reception
|
|
|
